Stay updated on Brentuximab & Nivolumab for Early Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Brentuximab & Nivolumab for Early Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Brentuximab & Nivolumab for Early Hodgkin Lymphoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    A centralized Locations section has been added listing all study sites by state (Alabama, California, Georgia, Illinois, Massachusetts, New Jersey, New York, Ohio, Pennsylvania, Tennessee, Texas, Utah). Removed individual state location subsections and applied revision v3.3.3.
    Difference
    1%
    Check dated 2025-12-18T21:35:04.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    Publications section now states entries are automatically filled from PubMed, and the page revision was updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-27T04:08:51.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Notice banner about government funding status was removed from the page, which does not affect the study details or core functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-19T21:42:54.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    No additions or deletions detected on the Study Details page for NCT03712202; the trial objectives, eligibility criteria, and listed locations remain as published.
    Difference
    0.3%
    Check dated 2025-10-29T02:51:54.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Major update to the page includes a funding/operating status notice and a new version tag (v3.2.0), replacing the previous v3.1.0.
    Difference
    2%
    Check dated 2025-10-07T15:44:35.000Z thumbnail image
  9. Check
    97 days ago
    Change Detected
    Summary
    The page updates the revision from v3.0.2 to v3.1.0, signaling a new version is released. If there are no other visible changes, this is a straightforward version bump with no additional content edits.
    Difference
    0.1%
    Check dated 2025-09-29T20:22:54.000Z thumbnail image

Stay in the know with updates to Brentuximab & Nivolumab for Early Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Brentuximab & Nivolumab for Early Hodgkin Lymphoma Clinical Trial page.